United States News Todas as matérias

ECARX Holdings (NASDAQ:ECX), a global mobility tech provider, announced today the appointment of Lone Fønss Schrøder as Chairperson of the Board, effective April 16, 2026.

Great Southern Bancorp (NASDAQ:GSBC), the holding company for Great Southern Bank, has released preliminary financial results for the first quarter ended March 31, 2026.

BW LPG (NYSE:BWLP), the world’s leading owner and operator of Very Large Gas Carriers (VLGCs), provided an operational update today regarding the first-quarter performance of its trading arm, BW Product Services.

PDS Biotechnology (NASDAQ:PDSB) announced the publication of interim Stage 1, Phase 2 clinical data for its lead antibody-drug conjugate (ADC) candidate, PDS01ADC, in JCO Oncology Advances on April 15, 2026.

Telix Pharmaceuticals (NASDAQ:TLX) has reached a critical clinical milestone with the dosing of the first patient in its pivotal Phase 3 IPAX BrIGHT trial.

Mesoblast (NASDAQ:MESO) has expanded its advanced therapy pipeline by acquiring an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform.

eToro (NASDAQ:ETOR) announced on Wednesday, April 15, 2026, that it has entered into a definitive agreement to acquire Zengo, a leading provider of self-custodial crypto wallets.

Organigram Global (NASDAQ:OGI) announced today the successful closing of its acquisition of Sanity Group, a leading German cannabis company.

Winmark (NASDAQ:WINA), known as "the Resale Company®," announced its financial results for the first quarter ended March 28, 2026.

Plumas Bancorp (NASDAQ:PLBC), the parent company of Plumas Bank, has reported record-breaking financial results for the first quarter ended March 31, 2026.

Toro (NASDAQ:TORO) has reported its financial results for the fourth quarter and full year ended December 31, 2025, a year characterized by significant corporate transformation and capital return initiatives.

Cosmos Health (NASDAQ:COSM), a diversified global healthcare group, has announced record-breaking financial results for the fiscal year ended December 31, 2025.

USA Rare Earth (NASDAQ:USAR) announced a major operational milestone on April 15, 2026, with the first commercial pour of yttrium metal at its subsidiary, Less Common Metals (LCM), located in Cheshire, UK.

Nixxy (NASDAQ:NIXX) has reported its financial results for fiscal year 2025, marking the successful conclusion of a multi-year strategic transformation.

Canaan (NASDAQ:CAN), a leading provider of high-performance computing solutions and a pioneer in Bitcoin mining hardware, has released its unaudited operational update for March 2026.

XTI Aerospace (NASDAQ:XTIA) has released its financial results for the full year 2025 and provided an optimistic outlook for 2026, marking its first comprehensive reporting period since the $40 million acquisition of Drone Nerds in late 2025.

Stereotaxis (NYSE:STXS), a pioneer in innovative robotic technologies for the treatment of arrhythmias and endovascular disease, announced today that it has entered into a definitive agreement to acquire Robocath.

Viant Technology (NASDAQ:DSP), a prominent player in AI-powered programmatic advertising, announced today that it has entered into a definitive agreement to acquire TVision Insights.

Raytheon, an RTX (NYSE:RTX) business, achieved a major milestone in its next-generation sensing portfolio on April 15, 2026, with the successful completion of the first flight test of the RAIVEN Staring sensing system.

60 Degrees Pharmaceuticals (NASDAQ:SXTP) announced on April 15, 2026, a strategic partnership with Runway Health to make ARAKODA (tafenoquine) available to U.S. travelers via a dedicated telehealth platform.

Immutep (NASDAQ:IMMP), a clinical-stage biotechnology company developing LAG-3 immunotherapies, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, eftilagimod alfa (efti), for the treatment of soft tissue sarcoma (STS).

NOV (NYSE:NOV) announced today that it has lowered its financial guidance for the first quarter of 2026, citing unforeseen operational and logistical disruptions caused by the escalating conflict in the Middle East.

Arbutus Biopharma (NASDAQ:ABUS), a clinical-stage biopharmaceutical company specializing in chronic infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for imdusiran (AB-729) for the treatment of chronic hepatitis B (cHBV).

Bitdeer Technologies Group (NASDAQ:BTDR) has released its operational update for March 2026, highlighting a period of hyper-growth in both its artificial intelligence infrastructure and core Bitcoin mining operations.